Home › NDC Lookup › Ingredients › Omeprazole › 51660-0029-27
Omeprazole 20 mg Tablet, Delayed Release — NDC 51660-0029-27 package photo

Omeprazole 20 mg Tablet, Delayed Release

by OHM LABORATORIES INC. · 2 BOTTLE in 1 CARTON (51660-029-27) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE
NDC 51660-0029-27
🏷️ FDA NDC (as labeled) 51660-029-27 billing pads the product segment with a zero
This package
Contains14 tablet, delayed release in 1 bottle Cost per ea$0.3832 NADAC Per package$10.73 / 28 tablets Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.6101/unit — full pricing hub ↓
Also comes in: 14 tablets 51660-0029-14 14 tablets 51660-0029-44
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Omeprazole (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jun 30, 2025 — Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules. (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0525-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 51660-029-27
Product NDC 51660-029
11-digit billing NDC 51660002927
NCPDP billing unit EA — each (per item)
RxCUI 402014
UNII KG60484QX9
Application # ANDA207891
SPL Set ID 35a95bec-51b9-465b-aa93-ad26afb87be8
Established class (EPC) Proton Pump Inhibitor
Mechanism of action Proton Pump Inhibitors; Cytochrome P450 2C19 Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-06-01
Route ORAL
Dosage form TABLET, DELAYED RELEASE
Substance OMEPRAZOLE
GPI-14 49270060000620
GPI class Omeprazole
GCN Seq No 054334
GCN 22228
HICL code 004673
Ingredient (HICL) Omeprazole
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4J
Therapeutic class — specific (HIC3) Proton-Pump Inhibitors
AHFS code 56:28.36.00
AHFS class Proton-Pump Inhibitors
FDB label name OMEPRAZOLE DR 20 MG TABLET
FDB brand name Omeprazole
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 51660-029-27 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 51660-0029-27. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Proton Pump Inhibitor class.

Pharmacologic class Proton Pump Inhibitor
Drug family (ATC) Proton pump inhibitors
How it works Proton Pump Inhibitors, Cytochrome P450 2C19 Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerOHM LABORATORIES INC.
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA207891 (ANDA)
Labeler code51660
First marketedJun 2019
Product typeHuman Otc Drug
Portfolio30 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name OMEPRAZOLE DR 20 MG TABLET Ingredient Omeprazole
📖 What it is MedlinePlus · NLM

Prescription omeprazole is used alone or with other medications to treat the symptoms of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 1 year of age and older. Prescription omeprazole is used to treat damage from GERD in adults and children 1 month of age and older. Prescription omeprazole is used to allow the esophagus to heal and prevent further damage to the esophagus in adults and children 1 year of age and older with G...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Omeprazole turns down your stomach's acid production by blocking the pump that makes acid in the first place. Depending on why you're taking it, that can mean relief from heartburn...
  • What exactly is omeprazole supposed to do for me?
  • Take it about 30 minutes before a meal, ideally before breakfast. Taking it before eating gives it the best chance to be absorbed and ready to work when your stomach starts produci...
  • When should I take it — before or after eating?
📖 Read our full Omeprazole guide →
9
Nutrient depletion considerations

Omeprazole may be associated with lower levels of 9 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Omeprazole nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color Brown
ShapeOval
Imprint20
Size12 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 5138Q19F1X
    Ammonia is a colorless gas made from nitrogen and hydrogen. It's used in medicines as a pH buffer to maintain the correct acidity level and help keep the product stable.
  • UNII 3SY5LH9PMK
    Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
  • UNII 8PJ61P6TS3
    Butyl alcohol is a clear liquid organic solvent derived from petroleum or natural sources. In medicines, it helps dissolve active ingredients and serves as a solvent in liquid formulations and some topical products.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 36BGF0E889
    Hypromellose acetate succinate is a modified plant cellulose used as a film coating on tablets and capsules. It helps protect the medicine and control where it dissolves in the digestive tract.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII P0NTE48364
    A plant-based thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a viscosity modifier to control texture in liquid or semi-solid formulations.
  • UNII 5KV86114PT
    A chemical compound used in medicines as a pH buffer and neutralizing agent. It helps maintain the proper acidity level in liquid formulations to improve stability and make the medicine easier to take.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII QU7E2XA9TG
    Sodium stearate is a salt derived from stearic acid, a natural fatty substance. It acts as a lubricant and binder in tablets and capsules, helping the medicine hold together and flow smoothly during manufacturing.
  • UNII 7CV7WJK4UI
    Sodium stearyl fumarate is a synthetic compound made from stearyl alcohol and fumaric acid. It acts as a lubricant and glidant in tablets and capsules, helping ingredients flow smoothly during manufacturing and preventing sticking.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

20 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesanhydrous lactose, hypromellose, hypromellose acetate succinate, iron oxide red, iron oxide yellow, lactose monohydrate, methyl cellulose, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, triethyl citrate and titanium dioxide. The imprinting ink contains ammonium hydroxide, black iron oxide, n-butyl alcohol, propylene glycol and shellac.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.383 $10.73 / 28 tablets
Medicaid paysCMS SDUD · 12 mo $0.6101 $17.08 / 28 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Jan 2026 May 2026 Sep 2026 $0.447 $0.383
▼ Down 10% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acid Reducer 20 mg 70000-0521-01 Cardinal 14 tablets $0.383 — FDA listed +0%
rugby omeprazole 20 mg 00536-1448-13 Rugby 14 tablets $0.383 — Availability likely —
omeprazole 20 mg 45802-0888-30 Padagis 1 tablet $0.383 — Availability likely —
good neighbor pharmacy omeprazole 20 mg 46122-0029-03 Amerisource 1 tablet $0.383 — Availability likely —
good neighbor pharmacy omeprazole 20 mg 46122-0281-04 Amerisource 14 tablets $0.383 — Availability likely —
Omeprazole 20 mg 46122-0739-03 AMERISOURCEBERGEN 14 tablets $0.383 — Discontinued —
Omeprazole 20 mgthis 51660-0029-27 OHM 14 tablets $0.383 — Availability likely —
Omeprazole 20 mg 68001-0441-39 BluePoint 14 tablets $0.383 — Availability likely —
leader omeprazole 20 mg 70000-0723-01 Cardinal 14 tablets $0.383 — Availability likely —
Omeprazole 20 mg 70677-1098-01 STRATEGIC 14 tablets $0.383 — Availability likely —
foster and thrive omeprazole 20 mg 70677-1104-01 Strategic 1 tablet $0.383 — Availability likely —
foster and thrive omeprazole 20 mg 70677-1275-01 Strategic 14 tablets $0.383 — Availability likely —
Omeprazole 20 mg 70677-0148-01 Strategic 14 tablets $0.424 — FDA listed +11%
Omeprazole 20 mg 83324-0011-14 CHAIN 14 tablets $0.459 — Availability likely +20%
Acid Reducer 20 mg 00536-1322-13 Rugby 14 tablets $0.473 — Availability likely +23%
Good Sense Omeprazole 20 mg 00113-0915-03 L. 14 tablets — — FDA listed —
Good Sense Omeprazole 20 mg 00113-1723-01 L. 14 tablets — — FDA listed —
good sense omeprazole delayed release 20 mg 00113-1803-03 L. 14 tablets — — FDA listed —
omeprazole 20 mg 00363-0007-01 Walgreen 14 tablets — — FDA listed —
omeprazole 20 mg 00363-0915-01 Walgreen 14 tablets — — FDA listed —
Acid Reducer 20 mg 00363-1008-05 WALGREEN 14 tablets — — FDA listed —
Omeprazole 20 mg 00363-1607-14 Walgreens 14 tablets — — FDA listed —
omeprazole 20 mg 00363-6101-03 Walgreen 14 tablets — — FDA listed —
Omeprazole 20.6 mg 00363-9510-14 Walgreens 14 tablets — — FDA listed —
Acid Reducer 20 mg 10202-0722-05 7-Eleven 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0018-01 Target 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0346-03 Target 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0915-01 Target 14 tablets — — FDA listed —
omeprazole 20 mg 11822-0453-01 Rite 14 tablets — — Discontinued —
omeprazole 20 mg 11822-0915-04 Rite 14 tablets — — Discontinued —
omeprazole 20 mg 11822-1190-01 Rite 14 tablets — — FDA listed —
Omeprazole 20 mg 21130-0018-14 Albertsons 14 tablets — — Discontinued —
Signature Care Omeprazole 20 mg 21130-0137-30 Safeway 1 tablet — — Discontinued —
signature care omeprazole 20 mg 21130-0401-01 Safeway 14 tablets — — FDA listed —
Omeprazole 20 mg 21130-0991-28 Living 14 tablets — — FDA listed —
Omeprazole 20 mg 25000-0091-76 MARKSANS 14 tablets — — FDA listed —
Acid Reducer 20 mg 30142-0077-01 KROGER 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0474-01 Kroger 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0557-01 Kroger 14 tablets — — FDA listed —
Omeprazole 20 mg 30142-0593-01 Kroger 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0992-14 THE 14 tablets — — FDA listed —
TopCare Omeprazole delayed release 20 mg 36800-0121-01 Topco 14 tablets — — FDA listed —
TopCare Omeprazole 20 mg 36800-0915-01 Topco 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 37000-0455-01 The 1 tablet — — FDA listed —
Prilosec OTC 20 mg 37000-0459-01 The 1 tablet — — FDA listed —
omeprazole 20 mg 37808-0401-01 H 14 tablets — — FDA listed —
omeprazole 20 mg 37808-0915-01 H 14 tablets — — FDA listed —
Omeprazole 20 mg 37835-0001-42 BI-MART 14 tablets — — FDA listed —
Acid Reducer 20 mg 37835-0189-14 Bi-Mart 14 tablets — — FDA listed —
equaline omeprazole 20 mg 41163-0915-01 United 14 tablets — — FDA listed —
omeprazole 20 mg 41250-0401-01 Meijer 14 tablets — — FDA listed —
omeprazole 20 mg 41250-0915-01 Meijer 14 tablets — — FDA listed —
careone omeprazole 20 mg 41520-0802-03 American 14 tablets — — FDA listed —
care one omeprazole 20 mg 41520-0915-03 American 14 tablets — — FDA listed —
omeprazole 20 mg 42507-0414-01 HyVee 14 tablets — — FDA listed —
omeprazole 20 mg 42507-0915-01 HyVee 14 tablets — — FDA listed —
Omeprazole 20 mg 43598-0286-25 Dr. 14 tablets — — FDA listed —
Omeprazole 20 mg 43598-0841-42 Dr. 14 tablets — — FDA listed —
equate omeprazole 20 mg 49035-0119-01 Wal-Mart 14 tablets — — FDA listed —
Equate omeprazole delayed release acid reducer 20 mg 49035-0915-01 Wal-Mart 14 tablets — — FDA listed —
Acid Reducer 20 mg 49035-0983-62 Wal-Mart 14 tablets — — FDA listed —
Omeprazole delayed release 20 mg 49483-0731-41 TIME 14 tablets — — FDA listed —
Omeprazole 20 mg 50090-6888-00 A-S 14 tablets — — FDA listed —
Acid Reducer 20 mg 53943-0016-05 DISCOUNT 14 tablets — — FDA listed —
exchange select omeprazole 20 mg 55301-0915-55 Army 1 tablet — — FDA listed —
Acid Reducer 20 mg 55315-0996-04 Fred's, 14 tablets — — FDA listed —
Acid Reducer 20 mg 55319-0037-05 Family 14 tablets — — FDA listed —
Omeprazole 20.6 mg 55319-0219-14 Family 14 tablets — — FDA listed —
Omeprazole 20 mg 55681-0306-14 Twin 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0215-01 Dolgencorp 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0712-01 Dolgencorp 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0915-02 Dolgencorp, 14 tablets — — FDA listed —
omeprazole 20 mg 56062-0401-01 Publix 14 tablets — — FDA listed —
omeprazole 20 mg 56062-0915-30 Publix 1 tablet — — FDA listed —
Acid Reducer 20 mg 57483-0120-42 INNOVUS 14 tablets — — FDA listed —
omeprazole 20 mg 57483-0840-42 INNOVUS 14 tablets — — FDA listed —
Omeprazole 20 mg 57896-0659-42 GERI-CARE 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0729-01 Aurohealth 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0826-05 Aurohealth 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0850-05 Aurohealth 14 tablets — — FDA listed —
omeprazole 20 mg 59640-0047-03 H 14 tablets — — FDA listed —
Omeprazole 20.6 mg 59726-0298-14 P 14 tablets — — FDA listed —
Omeprazole 20 mg 59726-0740-42 P 14 tablets — — FDA listed —
Omeprazole 20 mg 59726-0744-42 P 14 tablets — — FDA listed —
omeprazole 20 mg 59779-0503-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 59779-0580-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 62756-0377-11 Sun 14 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-2970-02 PLD 42 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-4080-02 PLD 1 tablet — — FDA listed —
Omeprazole 20.6 mg 63548-7370-02 PLD 42 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-8040-02 PLD 1 tablet — — FDA listed —
Omeprazole 20 mg 63868-0471-14 Chain 14 tablets — — Discontinued —
Acid Reducer 20 mg 63941-0006-05 Best 14 tablets — — FDA listed —
Omeprazole 20 mg 63941-0997-14 VALU 14 tablets — — FDA listed —
kirkland signature omeprazole 20 mg 63981-0915-55 Costco 1 tablet — — FDA listed —
Omeprazole, 24/7 Life by 7-Eleven 20.6 mg 66715-6550-04 Lil' 14 tablets — — FDA listed —
Acid Reducer 20 mg 67091-0316-14 Winco 14 tablets — — FDA listed —
Omeprazole 20.6 mg 67091-0464-14 WinCo 14 tablets — — FDA listed —
Omeprazole 20 mg 67296-2183-08 Redpharm 14 tablets — — FDA listed —
members mark omeprazole 20 mg 68196-0700-01 Sam's 14 tablets — — FDA listed —
members mark omeprazole 20 mg 68196-0915-01 Sam's 14 tablets — — Discontinued —
Berkley and Jensen Omeprazole 20 mg 68391-0915-55 BJWC 1 tablet — — FDA listed —
Omeprazole 20 mg 69168-0476-14 Allegiant 14 tablets — — FDA listed —
Omeprazole 20 mg 69230-0318-05 Camber 500 tablets — — FDA listed —
Acid Reducer 20 mg 69618-0054-42 RELIABLE 14 tablets — — FDA listed —
Omeprazole 20 mg 69842-0661-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 72036-0981-14 HARRIS 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0047-01 Amazon.com 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0401-01 Amazon.com 14 tablets — — FDA listed —
Amazon Basic Care Omeprazole 20 mg 72288-0409-01 Amazon.com 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0915-01 Amazon.com 14 tablets — — FDA listed —
careone omeprazole 20 mg 72476-0473-01 Retail 14 tablets — — FDA listed —
omeprazole 20 mg 72559-0014-06 Little 14 tablets — — FDA listed —
topcare omeprazole 20 mg 76162-0470-01 Topco 14 tablets — — FDA listed —
24 hr omeprazole 20 mg 79481-0075-01 Meijer, 14 tablets — — FDA listed —
equate omeprazole 20 mg 79903-0113-14 WALMART 14 tablets — — FDA listed —
Omeprazole 20 mg 79903-0305-28 Walmart 14 tablets — — FDA listed —
Omeprazole 20.6 mg 79903-0377-14 WALMART 14 tablets — — FDA listed —
Acid Reducer 20 mg 80136-0852-03 NORTHEAST 14 tablets — — FDA listed —
good now omeprazole 20 mg 82501-0915-00 Gobrands, 1 tablet — — FDA listed —
Omeprazole 20 mg 83324-0141-14 Chain 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 84126-0300-14 The 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 84126-0301-14 The 14 tablets — — FDA listed —
24 HOUR Omeprazole 20 mg 85828-0731-45 Grocery 14 tablets — — FDA listed —
Omeprazole 20 mg 53943-0038-14 Discount 14 tablets — — FDA listed —
Omeprazole 20 mg 72288-0934-01 Amazon.com 14 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2019
On the market since
Jun 2019
📍
2026
Currently FDA-listed
7 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 51660-0029-27, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
19.2K
Units reimbursed last 4 qtrs
725.4K
Gross reimbursed last 4 qtrs
$442.5K
Avg / prescription
$23.03
Avg / unit
$0.6101
Latest quarter Q4 2025
3.9KRx
Medicaid pays / ea
$0.6101
gross reimbursed
vs
NADAC / ea
$0.3832
acquisition cost
=
Spread
+$0.2269
+59% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
64% FFS 36% MCO
Fee-for-service · 12,268 Rx Managed care · 6,945 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 13,230 units · 231 per 100k residents MN Wisconsin: no data reported WI Michigan: 2,610 units · 26.0 per 100k residents MI New York: 30,908 units · 158 per 100k residents NY Vermont: no data reported VT New Hampshire: 3,919 units · 280 per 100k residents NH Oregon: 41,587 units · 982 per 100k residents OR Nevada: 15,021 units · 470 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 10,016 units · 146 per 100k residents IN Ohio: 33,320 units · 283 per 100k residents OH Pennsylvania: no data reported PA New Jersey: 15,634 units · 168 per 100k residents NJ Massachusetts: no data reported MA California: 439,014 units · 1,127 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 31,703 units · 364 per 100k residents VA Maryland: 72,703 units · 1,176 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 5,814 units · 108 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 6,054 units · 54.9 per 100k residents GA D.C.: no data reported DC Hawaii: 3,824 units · 266 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
26.01,176
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Maryland 1,176 /100k
2 California 1,127 /100k
3 Oregon 982 /100k
4 Nevada 470 /100k
5 Virginia 364 /100k
6 Ohio 283 /100k
7 New Hampshire 280 /100k
8 Hawaii 266 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
14 tablets this page51660-0029-27 19,213 Rx · $442,520
14 tablets51660-0029-44 8,312 Rx · $196,930
14 tablets51660-0029-14 2,236 Rx · $54,625
Drug total (last 4 qtrs): 29,761 Rx · 1,094,493 units · $694,075 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Omeprazole — the program that covers self-administered drugs. 14 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Omeprazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$75.01M
Claims incl. refills
7.1M
Beneficiaries
5.3M
Spend / beneficiary
$14.18
Spend / claim
$10.59
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Omeprazole — the ingredient across all brands.

Top reported reactions

Chronic Kidney Disease36,807
Nausea27,095
Fatigue26,259
Diarrhoea25,668
Acute Kidney Injury23,964
Dyspnoea21,145
Pain20,498

Age at onset

Neonate292
Infant271
Child706
Adolescent877
Adult32,838
Elderly30,558

Reporter sex

448,293 reports
Male · 40%
Female · 60%
Unknown · 0%

Serious outcomes

Hospitalization150,621
Death39,276
Life-threatening19,121
Disabling14,768
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 45,465 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
51660-0029-14 1 BOTTLE in 1 CARTON (51660-029-14) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.3832 / ea $5.36 2019-06-01 Active
51660-0029-27 You're viewing this 2 BOTTLE in 1 CARTON (51660-029-27) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.3832 / ea $10.73 2019-06-01 Active
51660-0029-44 3 BOTTLE in 1 CARTON (51660-029-44) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.3832 / ea $16.09 2019-06-01 Active

This pack effectively ties for the lowest per-ea cost of the 3 priced pack sizes ($0.3832 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 65% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in NDC 51660-0029-27?
NDC 51660-0029-27 is listed by the FDA — 2 bottle in 1 carton / 14 tablet, delayed release in 1 bottle.
What NDC number is used to bill for this package of Omeprazole 20 mg Tablet, Delayed Release?
Bill NDC 51660-0029-27 — the 11-digit billing format is 51660002927. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 31 words ▾

Use • treats frequent heartburn (occurs 2 or more days a week) • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect

⏱️ Dosage and Administration 164 words ▾

Directions • for adults 18 years of age and older • this product is to be used once a day (every 24 hours), every day for 14 days • it may take 1 to 4 days for full effect; some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment • swallow 1 tablet with a glass of water before eating in the morning • take every day for 14 days • do not take more than 1 tablet a day • do not use for more than 14 days unless directed by your doctor • swallow whole. Do not chew or crush tablets. Repeated 14-Day Courses (if needed) • you may repeat a 14-day course every 4 months • do not take for more than 14 days or more often than every 4 months unless directed by a doctor • children under 18 years of age: ask a doctor.

Heartburn in children may sometimes be caused by a serious condition.

⚠️ Warnings 220 words ▾

Warnings Allergy alert Do not use if you are allergic to omeprazole. Do not use if you have • trouble or pain swallowing food, vomiting with blood, or bloody or black stools • heartburn with lightheadedness, sweating or dizziness • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness • frequent chest pain These may be signs of a serious condition. See your doctor.

Ask a doctor before use if you have • had heartburn over 3 months. This may be a sign of a more serious condition. • frequent wheezing, particularly with heartburn • unexplained weight loss • nausea or vomiting • stomach pain Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.

Stop use and ask a doctor if • your heartburn continues or worsens • you need to take this product for more than 14 days • you need to take more than 1 course of treatment every 4 months • you get diarrhea • you develop a rash or joint pain If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 33 words ▾

Other information • read the directions and warnings before use • keep the carton. It contains important information. • store at 20 to 25° C (68 to 77° F) and protect from moisture

🧪 Active Ingredient 8 words ▾

Active ingredient(in each tablet) Omeprazole USP 20 mg

🧪 Inactive Ingredients 53 words ▾

Inactive ingredients anhydrous lactose, hypromellose, hypromellose acetate succinate, iron oxide red, iron oxide yellow, lactose monohydrate, methyl cellulose, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, triethyl citrate and titanium dioxide. The imprinting ink contains ammonium hydroxide, black iron oxide, n-butyl alcohol, propylene glycol and shellac.

🎯 Purpose 3 words ▾

Purpose Acid reducer

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 51660-0027-14 · Ohm 51660-0037-21 · Ohm →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.